An et al. (23) found that EGFL6 not only is associated with cancer cell proliferation, migration, invasion, and angiogenesis, but also promotes epithelial-to-mesenchymal transition (EMT) and tumor stem cell characteristics in breast cancer. This evidence concerns the gene EGFL6 and cancer.